Funding-round

Cognito Therapeutics - Series B Funding

CompanyCognito Therapeutics
Amount$73,000,000
CurrencyUSD
Announcement date2023-03-22
Round typeSeries B Funding
Primary source urlhttps://www.finsmes.com/2023/03/cognito-therapeutics-raises-73m-in-series-b-funding.html
Terms or valuationThe round, which brought total funding to $93M, was led by FoundersX Ventures with participation from Alzheimer’s Drug Discovery Foundation (ADDF), Starbloom Capital, IAG Capital and WS Investment Company. In addition to the financing, Dr. Rick Kuntz, MD, MSc, former Senior Vice President, Chief Medical and Scientific Officer of Medtronic and Helen Liang, Founder & Managing Partner at FoundersX, will join Cognito’s Board of Directors.

Participating investors